In natural product development, understanding how bioactive compounds interact with the human body is essential for designing effective products. Nutralytics’ Nutraverse™ AI platform offers quantitative insights into a compound’s bioactivity. Our newest feature predicts EC50, a measure of agonist potency, complementing our existing antagonist IC50 prediction capability and enhancing your ability to evaluate the health potential of natural products.
What Is EC50, and Why Does It Matter?
Agonists are compounds that activate target proteins such as receptors, enzymes, or entire biochemical pathways. Their potency is measured by the half-maximal effective concentration (EC50)—the concentration required to achieve 50% of the maximum biological effect.
Traditionally, determining EC50 values involved labour-intensive experimental assays to analyse dose-response relationships. With our AI-powered model, Nutraverse™ predicts EC50 values directly from a compound’s chemical structure.
Key Highlights:
- Data-Driven Precision: Our model, trained on over 75,000 verified data points covering 498 unique human protein targets, delivers accurate predictions with an R² of 0.81 and an MSE of 0.12.
- Efficiency and Savings: By reducing the need for extensive laboratory assays, the model saves time and resources while providing actionable insights into compound performance.
“The EC50 model gives teams a clear path to creating products that don’t just meet expectations—they exceed them,” says Dr. John Ingram, CEO of Nutralytics.
The Nutraverse™ Advantage
Our EC50 prediction model is designed to help your team:
- Enhance Compound Selection: Identify the most promising bioactives early in the development process.
- Optimize Formulation Design: Adjust dosages and ingredient combinations with greater confidence.
- Reduce Time and Cost: Minimize the need for additional experimental screenings, accelerating time-to-market.
- Strengthen Health Claims: Build your products on robust, science-backed data in a competitive market.
Looking ahead, future enhancements to Nutraverse™ will include:
- Ki and Kd Models: For a deeper analysis of binding affinities.
- Molecular Insights: To predict bioavailability, understand mechanisms of action, and evaluate ingredient synergies.
- Integrated Contextual Data: Leveraging literature and patent databases to support and refine predictions.
Join the Nutraverse™ Revolution
In today’s market, where demand for natural and functional products continues to rise, scientific validation is more important than ever. Nutraverse™ turns EC50 predictions into practical strategies that enable you to:
- Discover Active Ingredients Faster
- Develop Tailored Formulations targeting specific health outcomes
- Support Robust Health Claims
We invite companies in the nutraceutical and functional foods sectors to participate in our Nutraverse™ trial program. Your feedback will help us refine the platform to better meet your needs.
Pre-register today at nutralytics.com and help shape the future of natural product innovation
